Lv31
250 积分 2024-05-06 加入
Pulmonary Arterial Hypertension
1小时前
待确认
POS1072 Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23-Receptor, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, Randomized, Double-Blind, Placebo-Controlled ICONIC-LEAD Trial
2个月前
已关闭
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
2个月前
已完结
Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta‐analysis
2个月前
已完结
Myelodysplastic Syndromes
2个月前
已完结
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
3个月前
已完结
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension
3个月前
已完结
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
3个月前
已完结
Sotatercept as add-on therapy for advanced PAH
3个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
3个月前
已完结
皖公网安备34019202002308
